Package Leaflet: Information for the User
Ofloxacino Altan 2 mg/ml solution for infusion EFG
Read all of this leaflet carefully before you start using this medicine because it contains important information for you.
Contents of the pack:
This medicinal product contains ofloxacin, an antibiotic belonging to a group called fluoroquinolones. This medicinal product works by killing the bacteria that cause infections.
Antibiotics are used to treat bacterial infections and are not effective against viral infections such as the flu or the common cold. It is important that you follow the instructions regarding dosage, administration interval, and treatment duration as indicated by your doctor. Do not store or reuse this medicinal product. If you have any leftover antibiotic after completing treatment, return it to the pharmacy for proper disposal. Do not throw away medicines via wastewater or household waste. |
This medicinal product is indicated for the treatment of the following infections in adult patients:
Do not use Ofloxacino Altan:
The signs of an allergic reaction include: rash, swallowing or breathing problems, swelling of the lips, face, throat, or tongue.
Warnings and precautions
Before you start using this medicinal product
You should not use antibacterial medicines that contain fluoroquinolones or quinolones, including Ofloxacino Altan, if you have experienced any serious side effects in the past when using a quinolone or fluoroquinolone. If this is the case, you should inform your doctor as soon as possible.
Talk to your doctor, pharmacist, or nurse before you start using this medicinal product
Very rare reports of potentially life-threatening skin rashes (Stevens-Johnson Syndrome, Toxic Epidermal Necrolysis) have been communicated with the use of Ofloxacino Altan. The symptoms can include: flu-like symptoms followed by a painful red or purple rash that spreads and blisters form. If you develop any of the above symptoms, you should stop using the medicinal product and inform your doctor immediately (see section 4).
Ofloxacino Altan is not recommended if it is suspected that you have a MRSA infection.
While being treated with Ofloxacino Altan, avoid exposure to intense sunlight and do not use UV lamps or sunbeds, as your skin may be more sensitive to light.
Consult an ophthalmologist immediately if you experience any changes in your vision or have any problems with your eyes.
If you experience pain in your fingers or toes while being treated with Ofloxacino Altan, inform your doctor or nurse immediately.
If you are going to have any urine tests, it is important that you inform your doctor that you are being treated with this medicinal product, as it may alter the results.
If you are not sure if any of the above applies to you, talk to your doctor, pharmacist, or nurse before taking this medicinal product.
During treatment with this medicinal product
Rarely, pain and swelling in the joints and inflammation or rupture of tendons may occur. The risk is greater if you are an elderly person (over 60 years old), have received an organ transplant, have kidney problems, or are being treated with corticosteroids. Tendon inflammation and rupture can occur within the first 48 hours of treatment and even several months after stopping treatment with Ofloxacino Altan. At the first sign of pain or inflammation of a tendon (e.g., in the ankle, wrist, elbow, shoulder, or knee), stop using Ofloxacino Altan, contact your doctor, and rest the affected area. Avoid any unnecessary exercise, as this could increase the risk of tendon rupture.
Rarely, you may experience symptoms of nerve damage (neuropathy) such as pain, burning, tingling, numbness, and/or weakness, especially in your feet and legs or hands and arms. If this happens, stop using Ofloxacino Altan and inform your doctor immediately to prevent the development of a potentially irreversible disorder.
If you feel a sudden, severe pain in your chest, abdomen, or back, which can be symptoms of aortic dissection or aneurysm, go immediately to the emergency room. The risk may increase if you are receiving systemic corticosteroid treatment.
If you start to experience sudden shortness of breath, especially when lying down, or if you notice swelling in your ankles, feet, or abdomen, or the appearance of heart palpitations (feeling of rapid or irregular heartbeat), inform your doctor immediately.
Severe, long-lasting, and potentially irreversible side effects
Antibacterial medicines that contain fluoroquinolones or quinolones, including Ofloxacino Altan, have been associated with very rare but serious side effects, some of which were long-lasting (persisting for months or years), disabling, or potentially irreversible. This includes pain in the tendons, muscles, and joints of the upper and lower limbs, difficulty walking, abnormal sensations such as pins and needles, tingling, prickling, numbness, or burning (paresthesia), sensory disorders such as decreased vision, taste, smell, and hearing, depression, decreased memory, intense fatigue, and severe sleep disorders.
If you experience any of these side effects after using Ofloxacino Altan, contact your doctor immediately before continuing treatment. You and your doctor will decide whether to continue or not, also considering the use of an antibiotic from another class.
Children and adolescents
This medicinal product should not be used in children or adolescents who are still growing.
Other medicines and Ofloxacino Altan
Tell your doctor, pharmacist, or nurse if you are using, have recently used, or might use any other medicines, including those obtained without a prescription, homeopathic medicines, herbal remedies, and other health-related products, as it may be necessary to interrupt treatment or adjust the dose of one of them.
Tell your doctor if you are taking or have recently taken any of the following medicines:
Other medicines that can alter the heart rhythm:
The following medicines may change the way Ofloxacino Altan works or Ofloxacino Altan may change the way some of these medicines work:
The following medicines, when used with Ofloxacino Altan, may increase the possibility of side effects:
Using Ofloxacino Altan with food and drinks
Do not drink alcohol while taking Ofloxacino Altan, as it may make you feel dizzy or drowsy.
Pregnancy, breastfeeding, and fertility
If you are pregnant or breastfeeding, think you may be pregnant, or are planning to have a baby, ask your doctor or pharmacist for advice before using this medicinal product.
This medicinal product should not be administered if you are pregnant or breastfeeding, as ofloxacin passes into breast milk.
Driving and using machines
This medicinal product may cause dizziness or drowsiness and vision disturbances; therefore, you should not drive or use machines while using this medicinal product.
Ofloxacino Altan contains sodium
This medicinal product contains 334 mg of sodium (a major component of cooking/table salt) in each 100 ml bag. This is equivalent to 16.7% of the maximum recommended daily intake of sodium for an adult.
Ofloxacino Altan will normally be administered by a doctor or nurse, as it needs to be administered as a slow infusion (drip) into a vein.
When you are administered Ofloxacino Altan, if your vision is affected or if your eyes seem to be affected in any other way, consult an ophthalmologist immediately.
While being treated with ofloxacin, avoid exposure to direct sunlight and do not use sunlamps or sunbeds.
Follow exactly the administration instructions of this medicinal product as indicated by your doctor. If in doubt, consult your doctor, pharmacist, or nurse again.
The duration of treatment will depend on the type and/or severity of the infection and will be determined by your doctor.
Treatment should not last more than 2 months.
Once your illness has improved, your doctor may switch your medicine to ofloxacin tablets.
The dose of ofloxacin depends on the type and severity of the infection. Your doctor will decide the amount of Ofloxacino Altan you should use.
The recommended dose for adults is between 200 and 800 mg per day.
A daily dose of up to 400 mg of ofloxacin can be administered as a single dose.
Daily doses above 400 mg should be divided into two separate doses and administered at approximately equal intervals.
Your doctor should adjust the dose in case of liver or kidney disease.
Use in elderly patients over 65 years
Although it is not necessary to adjust the dose due to age, your doctor should pay special attention to kidney function and adjust the dose accordingly.
If you use more Ofloxacino Altan than you should
Your doctor will carefully calculate the amount of Ofloxacino Altan that you should be administered. Therefore, it is unlikely that your doctor or nurse will administer too much of this medicinal product. But if you think you have been administered too much or too little Ofloxacino Altan, inform your doctor or nurse.
The following effects may occur: confusion, feeling of dizziness, loss of consciousness, convulsions (seizures), nausea, or bleeding in the stools.
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, phone: 915 620 420, indicating the medicinal product and the amount taken. It may be necessary to go to the hospital. It is recommended to take the packaging and the leaflet of the medicinal product to the healthcare professional.
If you forget to use Ofloxacino Altan
Your doctor or nurse will have instructions on when to administer the medicinal product. It is unlikely that you will not be administered the medicinal product as prescribed. If you think you may have forgotten a dose, consult your doctor or nurse.
If you stop treatment with Ofloxacino Altan
Your doctor will indicate the appropriate dose and duration of treatment with this medicinal product. Do not stop treatment before completing the prescribed course, as you may not achieve the desired effect.
If you have any further questions on the use of this medicinal product, ask your doctor, pharmacist, or nurse.
Like all medicines, this medicine can cause adverse effects, although not all people suffer from them.
After administering this medicine, the following adverse effects have been reported as possible:
Report immediately to your doctor or nurse if you have any of the following serious adverse effects:
Very Rare (affect less than 1 in 10,000 people)
Rare (affect less than 1 in 1,000 people and more than 1 in 10,000 people)
Unknown (cannot be estimated from available data)
Inform your doctor if any of the following adverse effects become severe or last more than a few days:
Uncommon (affect less than 1 in 100 people and more than 1 in 1,000 people)
Rare (affect less than 1 in 1,000 people and more than 1 in 10,000 people)
Very Rare (affect less than 1 in 10,000 people)
Unknown (cannot be estimated from available data)
It is possible that Ofloxacino Altan may trigger a porphyria attack (a rare disease that affects metabolism) in some patients.
There have been reports of increased size and weakening or tearing of the aortic wall (aneurysms and dissections), which can cause a rupture and be fatal, and heart valve problems in patients who have received fluoroquinolones. See also section 2.
Adverse Effect Reporting
If you experience any type of adverse effect, consult your doctor, pharmacist, or nurse, even if it is a possible adverse effect that does not appear in this prospectus. You can also report them directly through the Spanish Pharmacovigilance System for Human Use Medicines: https://www.notificaram.es. By reporting adverse effects, you can contribute to providing more information on the safety of this medicine.
Keep this medicine out of sight and reach of children.
This medicine does not require any special storage temperature.
Keep in the original packaging to protect it from light and moisture.
Do not use this medicine after the expiration date shown on the packaging after CAD. The expiration date is the last day of the month indicated.
Medicines should not be thrown away in drains or trash. Ask your pharmacist how to dispose of packaging and medicines that are no longer needed. This will help protect the environment.
Composition of Ofloxacino Altan
Each 100 ml contains 200 mg of ofloxacin (as hydrochloride)
Appearance of the Product and Package Contents
This medicine is presented as a solution for infusion. Each package contains a PVC bag with 100 ml of solution.
Marketing Authorization Holder and Manufacturer
Marketing Authorization Holder
Altan Pharmaceuticals, S.A.
C/ Cólquide 6, Portal 2, 1ª planta, oficina F
Edificio Prisma
28230 Las Rozas. MADRID (Spain)
Manufacturer
Altan Pharmaceuticals, S.A.
Poligono Industrial de Bernedo s/nº
01118 – Álava (Spain)
Date of the Last Revision of this Prospectus:May 2025
Detailed information about this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) (http://www.aemps.gob.es/)
-----------------------------------------------------------------------------------------------
This information is intended only for healthcare professionals:
Method of Administration
The solution of Ofloxacino Altan should only be administered by slow intravenous infusion, this administration will be performed once or twice a day. The infusion time of the Ofloxacino Altan solution should not be less than 30 minutes for 200 mg, this is especially important when ofloxacin is administered concomitantly with medications that may cause a decrease in blood pressure or with anesthetics that contain barbiturics.
Usually, individual doses should be administered at approximately equal intervals.
The infusion solution can be infused directly or diluted with compatible solutions.
This medicine is compatible with physiological saline solution, Ringer lactate, and 5% glucose or fructose solutions. Compatibility with other solutions has not been verified.
General dosage recommendations. The dose of ofloxacin depends on the type and severity of the infection. A daily dose of up to 400 mg of ofloxacin can be administered as a single dose. In this case, it is preferable to administer ofloxacin in the morning.
Daily doses of more than 400 mg should be divided into two separate doses and administered at approximately equal intervals.
Adults:The usual intravenous doses in adults are:
Acute exacerbation of chronic bronchitis, community-acquired pneumonia: 200 mg twice a day.
Complicated skin and soft tissue infections: 400 mg twice a day.
The dose can be increased to 400 mg twice a day in severe or complicated infections.
Indication | Daily Dosage Regimen (according to severity) | Treatment Duration (according to severity) |
Complicated urinary tract infections | 200 mg twice a day (can be increased to 400 mg twice a day) | 7 - 21 days |
Pyelonephritis | 200 mg twice a day (can be increased to 400 mg twice a day) | 7-10 days (can be extended to 14 days) |
Acute prostatitis Chronic prostatitis | 200 mg twice a day (can be increased to 400 mg twice a day) | 2-4 weeks* 4-8 weeks |
Orchepididymitis | 200 mg twice a day (can be increased to 400 mg twice a day) | 14 days |
Pelvic inflammatory disease | 400 mg twice a day | 14 days |
Ofloxacin tablets can also be used to complete a treatment course in patients who have shown improvement during initial treatment with intravenous ofloxacin.
Once opened, the PVC bag of this medicine should be used immediately.
Remove the overbag immediately before administration. Discard if alterations are observed in the packaging or liquid.
The treatment duration is determined based on the response of the causative organisms and the clinical picture. As with all antibacterial agents, treatment with ofloxacin should continue for at least 3 days after the fever and symptoms have subsided.
In most cases of acute infection, a 7- to 10-day treatment is sufficient. Once the patient's condition has improved, the administration method should be changed from parenteral to oral, usually with the same total daily dose.
Treatment should not exceed 2 months in duration.
Dosage in Patients with Renal Impairment
In patients with renal impairment, the following oral or intravenous doses are recommended:
CREATININE CLEARANCE | DOSE UNIT mg* | NUMBER / 24h | INTERVALS h |
50 – 20 ml/min | 100 – 200 | 1 | 24 |
< 20 ml/min** or hemodialysis or peritoneal dialysis | 100 or 200 | 1 1 | 24 48 |
*according to the indication or dosage interval.
** The serum concentration of ofloxacin should be monitored in patients with severe renal impairment and in patients on dialysis.
When creatinine clearance cannot be measured, it can be estimated with reference to serum creatinine levels using the following Cockcroft formula for adults:
Weight (kg) x (140-age in years)
Men: ClCr (ml/min) =
72 x serum creatinine (mg/dl)
or
Weight (kg) x (140-age in years)
ClCr (ml/min) =
0.814 x serum creatinine (µmol/dl)
Women: ClCr (ml/min) = 0.85 x (previous value)
Dosage in Case of Hepatic Impairment(e.g., cirrhosis with ascites)
It is recommended that the maximum daily dose of ofloxacin should not exceed 400 mg, due to possible reduced excretion.
Pediatric Population
Ofloxacin is not indicated for use in children or adolescents in growth.
Elderly Patients
No dose adjustment of ofloxacin is required in the elderly population. However, special attention should be paid to renal function in elderly patients, and the dose should be adjusted accordingly (see section 4.4 Prolongation of the QT interval).